You are currently viewing a new version of our website. To view the old version click .

Recent Advances in Glaucoma: Diagnosis and Treatment

Special Issue Information

Dear Colleagues,

Glaucoma is a condition with an increased prevalence all over the world; after cataracts it is the main cause of visual impairment. The identification of the disease and its etiopathogenesis as well as risk factors leads to its early diagnosis and a reduction in the risk of progression at an important moment of the disease.

Once diagnosed, there are new innovations in its management and in reducing intraocular pressure, such as laser therapy and minimally invasive surgery.

The prediction of glaucoma progression through artificial intelligence tools is a widely debated topic recently.

Dear colleagues, this Special Issue addresses articles and reviews that include new methods for the diagnosis and treatment of glaucoma.

Dr. Nicoleta Anton
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vision is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • glaucoma
  • pathogenesis
  • laser therapy
  • shunt therapy
  • new technology
  • artificial intelligence

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vision - ISSN 2411-5150